Literature DB >> 16060878

Septic, CD-30 positive febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta.

Mark D Herron1, John F Bohnsack, Sheryll L Vanderhooft.   

Abstract

We report life-threatening febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta in an 8-year-old girl. Hemorrhagic-crusted papules and plaques covered over 90% of the patient's body, leaving her susceptible to Pseudomonas aeruginosa and Staphylococcus epidermidis bacteremia as well as Candida parapsilosis fungemia. Sepsis delayed definitive treatment of the underlying cutaneous disease for 2 weeks. Combined therapy with methotrexate and cyclosporin caused remission of the process. Although immunohistochemistry revealed CD-30 positive cells, suggesting the diagnosis of lymphomatoid papulosis, the histopathology was most compatible with pityriasis lichenoides et varioliformis acuta. A partial loss of CD2 and CD5 in the predominant CD3 T-cell lymphocytes suggested a clonal proliferation. Elevated soluble interleukin-2 receptor levels reflected marked T-cell activation, and the downward trend of the levels during treatment coincided with clinical regression of this inflammatory dermatosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16060878     DOI: 10.1111/j.1525-1470.2005.22418.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Febrile ulceronecrotic Mucha-Habermann disease.

Authors:  F-X Lejuste; C Michaux; C Lehners; N Calteux
Journal:  BMJ Case Rep       Date:  2013-10-14

2.  Pityriasis Lichenoides et Varioliformis Acuta as a Complication of COVID-19 Infection.

Authors:  Henriette De La Garza; Elie Saliba; Monica Rosales Santillan; Candice Brem; Neelam A Vashi
Journal:  Dermatopathology (Basel)       Date:  2022-07-05

3.  Methotrexate Treatment in Children with Febrile Ulceronecrotic Mucha-Habermann Disease: Case Report and Literature Review.

Authors:  Isil Bulur; Hilal Kaya Erdoğan; Zeynep Nurhan Saracoglu; Deniz Arık
Journal:  Case Rep Dermatol Med       Date:  2015-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.